Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Fetal programming of atherosclerosis: possible role of the mitochondria.

Leduc L, Levy E, Bouity-Voubou M, Delvin E.

Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):127-30. doi: 10.1016/j.ejogrb.2009.12.005. Epub 2010 Jan 6. Review.

PMID:
20053495
2.

Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species.

Amaral S, Oliveira PJ, Ramalho-Santos J.

Curr Diabetes Rev. 2008 Feb;4(1):46-54. Review.

PMID:
18220695
3.

In utero origins of adult insulin resistance and vascular dysfunction.

Thompson JA, Regnault TR.

Semin Reprod Med. 2011 May;29(3):211-24. doi: 10.1055/s-0031-1275522. Epub 2011 Jun 27. Review.

PMID:
21710397
4.

Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.

Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M.

Curr Med Chem. 2009;16(35):4654-67. Review.

PMID:
19903143
5.

Mitochondrial dysfunction in atherosclerosis.

Madamanchi NR, Runge MS.

Circ Res. 2007 Mar 2;100(4):460-73. Review.

6.

[Foetal programming of nutrition-related chronic diseases].

Delisle H.

Sante. 2002 Jan-Mar;12(1):56-63. Review. French.

7.

Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.

Jansson T, Powell TL.

Clin Sci (Lond). 2007 Jul;113(1):1-13. Review.

PMID:
17536998
9.

Oxidative stress, endothelial dysfunction and atherosclerosis.

Victor VM, Rocha M, Solá E, Bañuls C, Garcia-Malpartida K, Hernández-Mijares A.

Curr Pharm Des. 2009;15(26):2988-3002. Review.

PMID:
19754375
10.

Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis.

Puddu P, Puddu GM, Galletti L, Cravero E, Muscari A.

Cardiology. 2005;103(3):137-41. Epub 2005 Jan 19. Review.

PMID:
15665536
11.

Endothelial dysfunction in obesity: etiological role in atherosclerosis.

Meyers MR, Gokce N.

Curr Opin Endocrinol Diabetes Obes. 2007 Oct;14(5):365-9. Review.

PMID:
17940464
12.

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.

Cersosimo E, DeFronzo RA.

Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):423-36. Review.

PMID:
16506274
13.
14.

Endothelial function and oxidative stress in cardiovascular diseases.

Higashi Y, Noma K, Yoshizumi M, Kihara Y.

Circ J. 2009 Mar;73(3):411-8. Epub 2009 Feb 4. Review.

15.

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, Vécsei L.

J Neurol Sci. 2007 Jun 15;257(1-2):221-39. Epub 2007 Apr 25. Review.

PMID:
17462670
16.

Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.

Shen GX.

Can J Physiol Pharmacol. 2010 Mar;88(3):241-8. doi: 10.1139/Y10-018. Review.

PMID:
20393589
17.

Oxidative stress and endothelial dysfunction: say NO to cigarette smoking!

Grassi D, Desideri G, Ferri L, Aggio A, Tiberti S, Ferri C.

Curr Pharm Des. 2010;16(23):2539-50. Review.

PMID:
20550504
18.

Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD.

Singhal A.

Proc Nutr Soc. 2005 Feb;64(1):15-22. Review.

PMID:
15877918
19.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
20.

Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction.

Mehta JL, Rasouli N, Sinha AK, Molavi B.

Int J Biochem Cell Biol. 2006;38(5-6):794-803. Epub 2006 Jan 18. Review.

PMID:
16442834

Supplemental Content

Support Center